000 02417 a2200661 4500
005 20250514203752.0
264 0 _c20050111
008 200501s 0 0 eng d
022 _a1078-0432
024 7 _a10.1158/1078-0432.CCR-04-0525
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEisenbeis, Charles F
245 0 0 _aCombination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I study.
_h[electronic resource]
260 _bClinical cancer research : an official journal of the American Association for Cancer Research
_cSep 2004
300 _a6101-10 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_xadministration & dosage
650 0 4 _aAntibodies, Monoclonal, Murine-Derived
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aCombined Modality Therapy
_xmethods
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aInterleukin-2
_xadministration & dosage
650 0 4 _aKiller Cells, Natural
_ximmunology
650 0 4 _aLeukocytes
_ximmunology
650 0 4 _aLeukocytes, Mononuclear
_xmetabolism
650 0 4 _aLymphoma, B-Cell
_ximmunology
650 0 4 _aLymphoma, Non-Hodgkin
_ximmunology
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, SCID
650 0 4 _aMiddle Aged
650 0 4 _aRituximab
650 0 4 _aTime Factors
650 0 4 _aTreatment Outcome
700 1 _aGrainger, Andrew
700 1 _aFischer, Beth
700 1 _aBaiocchi, Robert A
700 1 _aCarrodeguas, Lester
700 1 _aRoychowdhury, Sameek
700 1 _aChen, Lei
700 1 _aBanks, Amy L
700 1 _aDavis, Thomas
700 1 _aYoung, Donn
700 1 _aKelbick, Nicole
700 1 _aStephens, Julie
700 1 _aByrd, John C
700 1 _aGrever, Michael R
700 1 _aCaligiuri, Michael A
700 1 _aPorcu, Pierluigi
773 0 _tClinical cancer research : an official journal of the American Association for Cancer Research
_gvol. 10
_gno. 18 Pt 1
_gp. 6101-10
856 4 0 _uhttps://doi.org/10.1158/1078-0432.CCR-04-0525
_zAvailable from publisher's website
999 _c15140625
_d15140625